ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: New Clinical Oncology RFP Ready Soon; CCIRC, Joftes Agree On Funding Method For Symposia

March 9, 1979

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

In Brief: Flood At Ohio’s Arthur James Cancer Hospital Sets Back Opening; Biometry Article Honored

January 19, 1990